Skip to product information
1 of 1

Shulph Ink

Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2: The Path to Bedside Management

Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2: The Path to Bedside Management

Dispatches within 7 to 10 working days
Regular price £115.91 GBP
Regular price £139.99 GBP Sale price £115.91 GBP
17% OFF Sold out
Tax included. Shipping calculated at checkout.

YOU SAVE £24.08

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2: The Path to Bedside Management

This book aims to gather current knowledge about brain and spinal cord tumors to better help patients. It covers topics such as background and epidemiology, genetics, immunology, histopathology, imaging, clinical manifestations, therapeutic approaches, surgical intervention, chemotherapy and radiotherapy, new therapeutic modalities, follow-up, and prognosis. The chapters discuss various types of tumors, including malignant glioma, benign glioma, meningiomas, ependymomas, medulloblastomas, pineal tumors, choroid plexus and ventricular tumors, neuroectodermal tumors, neuroepithelial tumors, pituitary gland tumors, craniopharyngioma, schwannomas, nerve-sheet tumors, hemangioblastomas, and other vascular-originating tumors. The book is useful for physicians of different specialties, mainly neurosurgeons, neurologists, neuropathologists, and neuroradiologists.

Format: Hardback
Length: 739 pages
Publication date: 15 August 2023
Publisher: Springer International Publishing AG

This comprehensive book aims to compile the most current knowledge on various aspects of brain and spinal cord tumors, with the ultimate goal of providing better assistance to patients. Brain tumors, which account for approximately 5-9% of all human neoplasms, are particularly prevalent in children, ranking among the most common neoplasms of this age group. By gaining deeper insights into the nature and characteristics of these tumors, we can make more informed decisions for each patient, aiming to achieve the best possible outcomes.

While surgical resection, chemotherapy, and radiotherapy have long been considered the standard of care for benign and/or malignant central nervous system (CNS) tumors, new therapeutic approaches, such as immunotherapy, have recently emerged as viable options. In some cases, tumors may be inoperable, or patients may not respond well to other treatment modalities after multiple recurrences.

The second volume of this book specifically focuses on clinical aspects of brain and spinal cord tumors. Each chapter is carefully structured to provide a logical outline for the entire volume. The most important brain and spinal cord tumors are discussed in detail, covering topics such as background and epidemiology, genetics, immunology and molecular biology, histopathology and morphology, imaging and radiologic features, clinical manifestations, therapeutic approaches, surgical intervention, chemotherapy and radiotherapy, new therapeutic modalities, follow-up, and prognosis.

The chapters in this volume delve into the pathology of various brain and spinal cord tumors, including malignant glioma, benign glioma, meningiomas, ependymomas, medulloblastomas, pineal tumors, choroid plexus and ventricular tumors, neuroectodermal tumors of the CNS, neuroepithelial tumors of the CNS, pituitary gland tumors, and more. By comprehensively addressing these tumors, this book aims to serve as a valuable resource for healthcare professionals, researchers, and patients alike.


Dimension: 254 x 178 (mm)
ISBN-13: 9783031237041
Edition number: 1st ed. 2023

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details